X0201 4 2004-03-01 0000815838 NOVEN PHARMACEUTICALS INC NOVN 0001224100 STRAUSS ROBERT C C/O NOVEN PHARMACEUTICALS, INC. 11960 S.W. 144TH STREET MIAMI FL 33186 1 1 0 0 President, CEO & Chairman Common Stock ($.0001 Par Value) 2004-03-01 4 M 0 45000 6.18 A 146584 D Common Stock ($.0001 par value) 2004-03-01 4 S 0 20000 23.00 D 126584 D Common Stock ($.0001 par value) 2004-03-01 4 S 0 5000 22.40 D 121584 D Common Stock ($.0001 par value) 2004-03-01 4 S 0 15000 22.45 D 106584 D Common Stock ($.0001 par value) 2004-03-01 4 S 0 5000 22.20 D 101584 D Common Stock ($.0001 par value) 2004-03-01 4 M 0 19765 6.18 A 121349 D Common Stock ($.0001 par value) 2004-03-02 4 M 0 49782 6.18 A 171131 D Common Stock ($.0001 par value) 2004-03-02 4 S 0 9782 23.11 D 161349 D Common Stock ($.0001 par value) 2004-03-02 4 S 0 2500 22.705 D 158849 D Common Stock ($.0001 par value) 2004-03-02 4 S 0 7500 22.70 D 151349 D Common Stock ($.0001 par value) 2004-03-02 4 S 0 10000 22.66 D 141349 D Common Stock ($.0001 par value) 2004-03-02 4 S 0 10000 22.23 D 131349 D Common Stock ($.0001 par value) 2004-03-02 4 S 0 5000 22.0994 D 126349 D Common Stock ($.0001 par value) 2004-03-02 4 S 0 5000 22.07 D 121349 D Common Stock ($.0001 par value) 2004-03-03 4 M 0 630 6.18 A 121979 D Common Stock ($.0001 par value) 2004-03-03 4 S 0 630 23.26 D 121349 D Stock Option (Right to Buy) 6.18 2004-03-01 4 M 0 45000 0 D 2004-12-11 Common Stock ($.0001 par value) 45000 70177 D Stock Option (Right to Buy) 6.18 2004-03-01 4 M 0 19765 0 D 2004-12-11 Common Stock ($.0001 par value) 19765 50412 D Stock Option (Right to Buy) 6.18 2004-03-02 4 M 0 49782 0 D 2004-12-11 Common Stock ($.0001 par value) 49782 630 D Stock Option (Right to Buy) 6.18 2004-03-03 4 M 0 630 0 D 2004-12-11 Common Stock ($.0001 par value) 630 0 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2003. 10% exercisable after 12/12/1998; 20% exercisable after 12/12/1999; 20% exercisable after 12/12/2000; 25% exercisable after 12/12/2001; 25% exercisable after 12/12/2002. Robert C. Strauss 2004-03-03